SARTORIUS – OPTA® SFT
Opta® SFT Aseptic Tube Connectors
Connect with Simplicity, Flexibility and Reliability
Biopharmaceutical processes demand fast, reliable and sterile connections for fluid transfer. The Opta® SFT single-use connector is designed to form a sterile connection between two pre-sterilized components. Quick and easy to use, Opta® connectors are extensively validated and backed by 100% in-house integrity testing. The Opta® SFT is available as a standalone component for end-user assembly with silicone or TPE tubing or can be pre-designed into a single-use assembly.
Key Features
1. High Level of Security Connector couplings sealed with sterilizing-grade PES membrane, allowing for sterile fluid transfer in non-classified and classified environments.
2. Increased Reliability A 3-click operation ensures fast, repeatable and consistent operation.
3. Enhanced Risk Mitigation Male and female connector couplings make it possible to design flow direction into your process, preventing mistaken connections.
4. Assured Integrity Connectors are 100% integrity tested to assure the highest quality for sterile fluid transfer.
5. Ultra Safe Connection The thermal welds are extraordinarily stable and ensure a sterile connection.
Technical Specifications
| Connector body & collar: | Polycarbonate |
| Seal small connector: Seal large connector: | Santoprene EPDM |
| Membrane: | Hydrophobic polyethersulfone |
| Protective cap: | Polypropylene |
| Connections | |
| Small connector body: | 1/4”, 3/ 8” and 1/2” Hose Barb |
| Large connector body: | 3/4“ Hose Barb |
| Pressure resistance | |
| Max. operating pressure: | 3 bar (43.5 psi) at 40°C (104°F) |
| Sterilization Methods | |
| Gamma irradiation: | ≤ 50 kGy |
| Autoclaving: | 20 minutes at 121°C (250°F) |
Opta®Aseptic Fluid Transfer OptaOpta® Clipster – Sartorius
Key Industries
- Biopharmaceutical and Biotechnology
Brand
The Sartorius Group is a leading international partner of the biopharmaceutical industry and the research sector. We are helping biotech scientists and engineers across the entire globe to develop and manufacture medications from the first idea to production. So more people will have access to better medicine.
